Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

ResMed provides sleep medications and non-invasive ventilation based on a visionary technology shifting diagnosis, treatment, and management of breathing sleep disorder. They treat sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases.

Cardiocom is the leader in telemedicine solutions for daily remote patient monitoring and disease management. Cardiocom provides health professionals with home telemonitoring equipment and telehealth services to identify symptomatic patients and intervene early to prevent unnecessary hospitalizations. Cardiocom addresses CHF, COPD, Asthma, Diabetes, Hypertension and Obesity. We offer a variety of health monitoring product and service options to meet your organization's specific needs. Cardiocom can provide in-house case managers with the Cardiocom OMNIVISOR PRO® Patient Management System, TELESCALE® for CHF management and COMMANDER for complex patients with multiple diseases. Cardiocom's proven, proactive solutions for daily patient disease management result in improved quality of life and direct savings to the health management group.

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.

Biosite Incorporated provides diagnostic products and antibody development technologies for sever diseases. It provides seversl products such as Triage drug of abuse panel, a point-of-care diagnostic test for detecting overdosed prescription and illicit drugs; Triage TOX Drug Screen, a fluorescence immunoassay to detect abused drugs; Triage cardiac panel, a diagnosis aid for heart attack; and Triage BNP test, a diagnosis and assessment aid for the heart failure; and other products. It also provides Triage D-dimer test, an immunoassay for use as an aid in the assessment and evaluation of patients having disseminated intravascular coagulation or thromboembolic events. Furthermore, it offers medical education, technical service and support, and consulting services. Biosite Incorporated distributes its products through distributors in the United States and internationally. It was established in 1988 and is based in San Diego, California with sales offices in Switzerland, the Asia Pacific, the Netherlands, France, Germany, Italy, Spain, and the United Kingdom. Currently it operates as a subsidiary of Alere Inc.

Biotronik (Biotronik SE & Co. KG; Biotronik Worldwide) is a privately held multinational biomedical technology company headquartered in Berlin, Germany. The company offers complete solutions for diagnosis, treatment, and therapy support in the areas of cardiac rhythm management, electrophysiology and vascular intervention. In the area of cardiac rhythm management, Biotronik Home Monitoring® uses telemonitoring technology to provide doctors with up-to-date information for implant patients.

Corventis is committed to improving clinical outcomes and lowering healthcare costs by enabling the early detection of cardiovascular events while allowing patients to maintain an active lifestyle.

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Bodiguide, Inc. is an American private company. The firm manufactures anklet that monitors ankle swelling to manage heart failure.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Micro Motion, Inc. manufactures fluid density meters. It provides sensors for measuring hazardous materials, corrosive materials, high-temperature fluids and sanitary products. The company was founded in 1977 and is headquartered in Boulder, CO.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this international commercial growth strategy, DC Bead and ondansetron RapidFilm. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. Ondansetron RapidFilm is an oral thin film formulation of ondansetron used to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy and surgery. SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). Thymalfasin is being developed in an ongoing clinical trial for improvement of Influenza A (H1N1) vaccination.